Business Context and Reporting Period
This Form 8-K is filed by LMF Acquisition Opportunities, Inc. (LMAO), a Delaware corporation and emerging growth company, on July 28, 2022. The filing reports on two material events: the amendment of a promissory note with its Sponsor and the extension of the deadline to consummate an initial business combination with SeaStar Medical, Inc., a medical technology company.
Key Financial Metrics and Obligations
- Debt Obligation (Amended Note): LMAO amended its unsecured promissory note with LMFAO Sponsor, LLC, increasing the aggregate principal amount from $500,000 to $1,750,000. As of July 29, 2022, $910,000 had been drawn down to fund offering expenses.
- Extension Loan: The Sponsor deposited $1,035,000 (representing $0.10 per public share) into LMAO's trust account to facilitate the extension of the business combination deadline.
- Interest: Both the Amended Note and the Extension Loan are non-interest bearing.
- Liquidity: The filing does not provide a clear value for total cash on hand or working capital outside of the specific drawdowns and trust deposits mentioned.
Material Changes and Events
- Debt Increase: The principal amount of the Sponsor promissory note was increased by $1,250,000 to support expenses related to the initial business combination.
- Deadline Extension: The date by which LMAO must consummate a business combination was extended from July 29, 2022, to October 29, 2022.
- Target Company: The extension provides additional time to complete the proposed merger with SeaStar Medical, Inc.
Outlook, Risks, and Contingencies
- Repayment Terms (Amended Note): The note is payable in full upon consummation of the initial business combination. No amount is due if a combination is not completed by the 24th anniversary of the IPO.
- Repayment Terms (Extension Loan): If a business combination is completed by October 29, 2022, the Sponsor may elect to have the loan repaid from trust proceeds or converted into warrants at $1.00 per warrant. If no combination occurs by the deadline, repayment is limited to funds held outside the trust account.
- Risk of Failure: The company faces the risk of failing to complete the business combination by the new October 29, 2022 deadline, which would trigger specific liquidation or repayment scenarios.
Investor Verification Checklist
- Verify the exact terms of the Amended and Restated Promissory Note (Exhibit 10.1) regarding drawdown limits and repayment triggers.
- Confirm the status of the proposed business combination with SeaStar Medical, Inc. and any updated merger agreements.
- Review the Press Release (Exhibit 99.1) for details on the Sponsor's election regarding the conversion of the Extension Loan into warrants.
- Monitor the company's ability to secure additional funding if the October 29, 2022 deadline is not met.